Innate Pharma (IPHA) Non-Current Deffered Revenue (2017 - 2026)
Innate Pharma (IPHA) posted Non-Current Deffered Revenue of $147,620 for the quarter ended Jun 30, 2026, down 76.8% from $637,293 a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Non-Current Deffered Revenue came in at $3.19 million, up 378.7% from the prior year.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -24.4% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Non-Current Deffered Revenue was $666,720 in the year ended Dec 31, 2024 (-89.5%), $6.34 million in the year ended Dec 31, 2023 (-8.2%), $6.91 million in the year ended Dec 31, 2022 (-51.6%) and $14.3 million in the year ended Dec 31, 2021 (+10.8%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Non-Current Deffered Revenue since the quarter ended Jun 30, 2023.
- On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last four quarters, with growth averaging 38.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Innate Pharma | 152.76 Mn | 152.76 Mn | - | 147,619.96 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147,619.96 |
| Dec 31, 2025 | 3.29 Mn |
| Jun 30, 2025 | 637,293.30 |
| Dec 31, 2024 | 658,254.77 |
| Jun 30, 2024 | 3.01 Mn |
| Dec 31, 2023 | 6.31 Mn |
| Jun 30, 2023 | -12.00 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Jun 30, 2022 | -18.60 Mn |
| Dec 31, 2021 | 14.30 Mn |
| Jun 30, 2021 | -45.84 Mn |
| Dec 31, 2020 | 13.47 Mn |
| Jun 30, 2020 | 41.58 Mn |
| Dec 31, 2019 | 53.98 Mn |
| Dec 31, 2018 | 93.70 Mn |
| Dec 31, 2017 | 56.41 Mn |
API Access
Innate Pharma Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();